Concepedia
Statistics
Publications
8
Citations
290
H-Index
Active since
2017
Affiliations
University of Leeds(Current)
University of Liverpool
Institute of Structural and Molecular Biology
Rachel M. Johnson is an author at University of Leeds specializing in drug discovery, medicinal chemistry, and drug design.
Publications per year
2017–2020
Human TRPC5 structures reveal interaction of a xanthine-based TRPC1/4/5 inhibitor with a conserved lipid binding site
David J. Wright, Katie J. Simmons, Rachel M. Johnson et al. · Communications Biology · 2020 · 64 citations · Full text
Medicine, Medicinal Chemistry, Pharmacology +17
Structure-Based Identification and Characterization of Inhibitors of the Epilepsy-Associated KNa1.1 (KCNT1) Potassium Channel
Bethan A. Cole, Rachel M. Johnson, Hattapark Dejakaisaya et al. · iScience · 2020 · 56 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +16
In Silico Fragment-Based Design Identifies Subfamily B1 Metallo-β-lactamase Inhibitors
Ricky Cain, Jürgen Brem, David Zollman et al. · Journal of Medicinal Chemistry · 2017 · 41 citations · Full text
Pharmacy, Medicinal Chemistry, Pharmacology +17
Potent Tetrahydroquinolone Eliminates Apicomplexan Parasites
Martin J. McPhillie, Ying Zhou, Mark Hickman et al. · Frontiers in Cellular and Infection Microbiology · 2020 · 32 citations · Full text
Veterinary Medicine, Medicinal Chemistry, Pharmacology +17
X-ray and cryo-EM structures of inhibitor-bound cytochrome<i>bc</i><sub>1</sub>complexes for structure-based drug discovery
Kangsa Amporndanai, Rachel M. Johnson, Paul M. O’Neill et al. · IUCrJ · 2018 · 30 citations · Full text
Life Sciences, Biochemistry, Biology +13
1–5 of 8